Wellgistics Health Inc. Financials
This page shows Wellgistics Health Inc. (WGRX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Wellgistics Health Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Wellgistics Health Inc. has an operating margin of -401.7%, meaning the company retains $-402 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -33.9% the prior year.
Wellgistics Health Inc. carries a low D/E ratio of -0.00, meaning only $-0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 67/100, indicating a strong balance sheet with room for future borrowing.
Wellgistics Health Inc.'s current ratio of 0.09 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Wellgistics Health Inc. passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Wellgistics Health Inc. generates $0.11 in operating cash flow (-$10.9M OCF vs -$101.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Wellgistics Health Inc. earns $-68.3 in operating income for every $1 of interest expense (-$93.7M vs $1.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Wellgistics Health Inc. generated $23.3M in revenue in fiscal year 2025. This represents an increase of 28.7% from the prior year.
Wellgistics Health Inc.'s EBITDA was -$90.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1699.8% from the prior year.
Wellgistics Health Inc. reported -$101.3M in net income in fiscal year 2025. This represents a decrease of 1377.1% from the prior year.
Wellgistics Health Inc. earned $-1.43 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 853.3% from the prior year.
Cash & Balance Sheet
Wellgistics Health Inc. held $43K in cash against $55K in long-term debt as of fiscal year 2025.
Wellgistics Health Inc. had 105M shares outstanding in fiscal year 2025. This represents an increase of 105.4% from the prior year.
Margins & Returns
Wellgistics Health Inc.'s gross margin was -27.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 37.3 percentage points from the prior year.
Wellgistics Health Inc.'s operating margin was -401.7% in fiscal year 2025, reflecting core business profitability. This is down 367.8 percentage points from the prior year.
Wellgistics Health Inc.'s net profit margin was -433.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 396.1 percentage points from the prior year.
Capital Allocation
WGRX Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0M-61.3% | $7.8M-28.3% | $10.9M | N/A | $5.7M+12638.8% | $45K | N/A | N/A |
| Cost of Revenue | $2.8M-61.8% | $7.3M-28.4% | $10.2M | N/A | $5.2M+10828.6% | $47K | N/A | N/A |
| Gross Profit | $231K-54.3% | $506K-27.0% | $693K | N/A | $521K+20086.3% | -$3K | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $30.2M+520.8% | $4.9M-84.4% | $31.2M | N/A | $1.8M+215.3% | $570K+615.1% | $80K | N/A |
| Operating Income | -$31.5M-473.6% | -$5.5M+82.5% | -$31.3M | N/A | -$1.7M-204.5% | -$573K-618.4% | -$80K | N/A |
| Interest Expense | $1.4M+20.4% | $1.2M+8.2% | $1.1M | N/A | $138K+10412.9% | $1K-61.0% | $3K | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$34.3M-414.3% | -$6.7M+79.4% | -$32.4M | N/A | -$1.9M-225.1% | -$574K-590.9% | -$83K | N/A |
| EPS (Diluted) | $-0.46-318.2% | $-0.11+82.3% | $-0.62 | N/A | $-0.04-300.0% | $-0.01 | $0.00 | N/A |
WGRX Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $52.8M-2.7% | $54.2M-6.6% | $58.1M+1.3% | $57.3M | N/A | N/A | N/A | $338K |
| Current Assets | $12.8M-5.1% | $13.5M-18.4% | $16.6M+9.1% | $15.2M | N/A | N/A | N/A | $338K |
| Cash & Equivalents | $4.2M+907.0% | $420K-83.3% | $2.5M+144.7% | $1.0M | N/A | N/A | N/A | $1K |
| Inventory | $7.5M-17.0% | $9.0M-7.2% | $9.7M+2.3% | $9.5M | N/A | N/A | N/A | N/A |
| Accounts Receivable | $1.1M-49.1% | $2.2M-23.6% | $2.8M+3.8% | $2.7M | N/A | N/A | N/A | N/A |
| Goodwill | $16.2M0.0% | $16.2M0.0% | $16.2M0.0% | $16.2M | N/A | N/A | N/A | N/A |
| Total Liabilities | $46.0M-13.7% | $53.3M-0.5% | $53.6M+5.9% | $50.6M | N/A | N/A | N/A | $3.2M |
| Current Liabilities | $32.7M-22.8% | $42.4M-8.3% | $46.2M+21.5% | $38.0M | N/A | N/A | N/A | $2.9M |
| Long-Term Debt | $12.6M+24.8% | $10.1M-58.1% | $24.1M+110.6% | $11.5M | N/A | N/A | N/A | N/A |
| Total Equity | $6.8M+648.7% | $905K-79.8% | $4.5M-33.5% | $6.7M-32.6% | $10.0M+417.2% | -$3.1M-5.5% | -$3.0M-2.9% | -$2.9M |
| Retained Earnings | -$83.2M-70.2% | -$48.9M-15.8% | -$42.2M-332.4% | -$9.8M | N/A | N/A | N/A | -$2.9M |
WGRX Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.1M+45.4% | -$2.1M-54.3% | -$1.3M+48.6% | -$2.6M-352.9% | $1.0M+214.5% | $330K+956.3% | $31K | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$221K-67.6% | -$132K+51.7% | -$273K-134.0% | $803K+354.0% | -$316K | N/A | N/A | N/A |
| Financing Cash Flow | $5.2M+4419.7% | $114K-96.3% | $3.1M+51.2% | $2.1M+45405.9% | $5K+100.8% | -$538K-306.9% | $260K | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
WGRX Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.7%+1.2pp | 6.5%+0.1pp | 6.4% | N/A | 9.2%+15.0pp | -5.9% | N/A | N/A |
| Operating Margin | -1047.1%-976.5pp | -70.6%+218.0pp | -288.6% | N/A | -30.8%+1255.8pp | -1286.5% | N/A | N/A |
| Net Margin | -1139.0%-1053.4pp | -85.6%+212.9pp | -298.5% | N/A | -32.9%+1256.5pp | -1289.5% | N/A | N/A |
| Return on Equity | -506.3%+230.8pp | -737.1%-13.0pp | -724.1% | N/A | -18.7% | N/A | N/A | N/A |
| Return on Assets | -65.0%-52.7pp | -12.3%+43.5pp | -55.9% | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 0.39+0.1 | 0.32-0.0 | 0.36-0.0 | 0.40 | N/A | N/A | N/A | 0.12 |
| Debt-to-Equity | 1.86-9.3 | 11.16+5.8 | 5.39+3.7 | 1.70 | N/A | N/A | N/A | -1.12 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$12.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.09), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Wellgistics Health Inc.'s annual revenue?
Wellgistics Health Inc. (WGRX) reported $23.3M in total revenue for fiscal year 2025. This represents a 28.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Wellgistics Health Inc.'s revenue growing?
Wellgistics Health Inc. (WGRX) revenue grew by 28.7% year-over-year, from $18.1M to $23.3M in fiscal year 2025.
Is Wellgistics Health Inc. profitable?
No, Wellgistics Health Inc. (WGRX) reported a net income of -$101.3M in fiscal year 2025, with a net profit margin of -433.9%.
What is Wellgistics Health Inc.'s EBITDA?
Wellgistics Health Inc. (WGRX) had EBITDA of -$90.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Wellgistics Health Inc. have?
As of fiscal year 2025, Wellgistics Health Inc. (WGRX) had $43K in cash and equivalents against $55K in long-term debt.
What is Wellgistics Health Inc.'s gross margin?
Wellgistics Health Inc. (WGRX) had a gross margin of -27.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Wellgistics Health Inc.'s operating margin?
Wellgistics Health Inc. (WGRX) had an operating margin of -401.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Wellgistics Health Inc.'s net profit margin?
Wellgistics Health Inc. (WGRX) had a net profit margin of -433.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Wellgistics Health Inc.'s operating cash flow?
Wellgistics Health Inc. (WGRX) generated -$10.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Wellgistics Health Inc.'s total assets?
Wellgistics Health Inc. (WGRX) had $30.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Wellgistics Health Inc.'s current ratio?
Wellgistics Health Inc. (WGRX) had a current ratio of 0.09 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Wellgistics Health Inc.'s debt-to-equity ratio?
Wellgistics Health Inc. (WGRX) had a debt-to-equity ratio of -0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Wellgistics Health Inc.'s return on assets (ROA)?
Wellgistics Health Inc. (WGRX) had a return on assets of -332.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Wellgistics Health Inc.'s cash runway?
Based on fiscal year 2025 data, Wellgistics Health Inc. (WGRX) had $43K in cash against an annual operating cash burn of $10.9M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Wellgistics Health Inc.'s debt-to-equity ratio negative or unusual?
Wellgistics Health Inc. (WGRX) has negative shareholder equity of -$12.4M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Wellgistics Health Inc.'s Piotroski F-Score?
Wellgistics Health Inc. (WGRX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Wellgistics Health Inc.'s earnings high quality?
Wellgistics Health Inc. (WGRX) has an earnings quality ratio of 0.11x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Wellgistics Health Inc. cover its interest payments?
Wellgistics Health Inc. (WGRX) has an interest coverage ratio of -68.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Wellgistics Health Inc.?
Wellgistics Health Inc. (WGRX) scores 11 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.